Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock Patients

NCT03344627 is registered in ClinicalTrials.gov with Mahidol University as lead sponsor.

NCT NCT03344627
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03344627 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock Patients
Lead sponsor
Mahidol University
Phase
Not applicable
Overall status
Completed
Start date
November 27, 2017
Completion date
December 31, 2018
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carbapenem, clinical outcome, critical illness, morality, organ failure, multiple, pharmacodynamic, pharmacokinetic, sepsis, septic shock